AnaZeal Analyticals & Research Pvt. Ltd. is an FDA approved analytical testing unit with GLP facilities to perform some of the most sophisticated laboratory analysis for the pharmaceutical, bulk drugs, cosmetic and ayurvedic formulation industry at Unit I.
Our Unit II facility is a Clinical Research Unit is involved in Phase II-IV clinical trials. We are also approved by Drugs Controller General (India), for Bioequivalence/Bioavailability studies.
It has been promoted by technocrats having 25 years of Experience in Quality systems (UKMCA, South Africa, MCC, WHO GMP), analysis (Instrumental, Chemical, Microbiological, Biological), Bioequivalence/Bioavailability studies, Clinial Trials (Phase II to Phase IV) and documentation required for various overseas regulatory submission.
AnaZeal is the first customer-centric CRO. Founded by dedicated experts and built on an unwavering commitment to operational excellence, we are able to strategically balance science, medicine, operations, and commercial intelligence to achieve successful drug development.
We take a never satisfied approach. Tackling every clinical research program as an opportunity to demonstrate a deep commitment to each client's unique needs. We have successfully managed over 60 clinical trials across all geographical locations in India. Our expertise lies in fostering the development of life-changing medicines by integrating clinical trial methodology, operational acumen, and efficient technology.
Our Goal is to become your 'Trusted Partner' in Research
We are committed to achieve customer satisfaction by maintaining quality assurance and prompt service at all time.
We always maintain an effective quality management system through an active involvement of our key people.
We comply with all the statutory testing regulations to ensure the earliest release of the product.
We conduct appropriate training programs for all our people on a regular basis to achieve continuous improvement in accordance to out objective.
Our mission is to foster the development of life-changing medicines by integrating clinical trial methodology, operational acumen, and efficient technology.